Company profile: Signal Genetics
1.1 - Company Overview
Company description
- Provider of innovative molecular diagnostic services that help physicians make better-informed decisions in the care of patients with cancer; a commercial-stage molecular diagnostics company.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Signal Genetics
Yecuris
HQ: United States
Website
- Description: Provider of FRG KO liver-humanized mouse models and tools for applications including gene editing, drug metabolism, toxicology, and liver disease. Offers HepaCur human hepatocytes (fresh/cryopreserved), CuRx reagents for the FRG KO platform, gene and cell therapy services (in vitro/in vivo validation, custom hepatocyte transplantation), plus NASH/NAFLD and infectious disease models; reagents ship worldwide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Yecuris company profile →
Nextcode
HQ: United States
Website
- Description: Provider of sequence-based clinical diagnostics and genome interpretation solutions that address big data challenges, leveraging technology developed over more than 16 years at deCODE genetics to enable the widespread incorporation of genome sequence data into patient diagnosis and care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nextcode company profile →
Vector BioMed
HQ: United States
Website
- Description: Provider of state-of-the-art custom vector design and GMP manufacturing, specializing in Lentiviral vector production for research, pre-clinical, IND-enabling, and clinical trials using a serum-free, chemically-defined process; algorithm-based vector design optimized for titer, transduction, and transgene expression; custom assay development; and support services for clinical development and commercialization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vector BioMed company profile →
BioIVT
HQ: United States
Website
- Description: Provider of biological and in vitro products and services for biopharmaceutical, diagnostic, and biotechnology organizations. Offerings include in vivo ADME/PK studies, bioanalytical services, biospecimen characterization, consulting for drug R&D, long-term hepatocyte culture systems (HEPATOPAC and HEPATOMUNE), and Human AB Serum for cell culture.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioIVT company profile →
Arrayit
HQ: United States
Website
- Description: Provider of proprietary life science technologies and consumables for disease prevention, treatment, and cure, including DNA microarrays for gene expression and genotyping, protein microarrays (antigens, antibodies, peptides), microarrayers (manufacturing robots), microarray software for controller, quantification, analysis, and design, microarray tools (pins, printheads, hybridization cassettes), and microarray scanners (colorimetric, CCD, sub-micron fluorescence).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arrayit company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Signal Genetics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Signal Genetics
2.2 - Growth funds investing in similar companies to Signal Genetics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Signal Genetics
4.2 - Public trading comparable groups for Signal Genetics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →